Mid-cap and large-cap growth funds tend to have a lot of technology stocks and biotech stocks, and biotech stocks have really gotten pummeled too. It seems like there's been a flight from anything perceived to be risky.
We use cookies to enhance your browsing experience, analyze site traffic, and personalize content. By clicking "Got It!," you consent to our use of cookies.